| Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults LA Mandell, RG Wunderink, A Anzueto, JG Bartlett, GD Campbell, ... Clinical infectious diseases 44 (Supplement_2), S27-S72, 2007 | 8295 | 2007 |
| Community-acquired pneumonia requiring hospitalization among US adults S Jain, WH Self, RG Wunderink, S Fakhran, R Balk, AM Bramley, C Reed, ... New England Journal of Medicine 373 (5), 415-427, 2015 | 2309 | 2015 |
| Community-acquired pneumonia requiring hospitalization among US children S Jain, DJ Williams, SR Arnold, K Ampofo, AM Bramley, C Reed, ... New England Journal of Medicine 372 (9), 835-845, 2015 | 1733 | 2015 |
| MERS, SARS and other coronaviruses as causes of pneumonia Y Yin, RG Wunderink Respirology 23 (2), 130-137, 2018 | 1583 | 2018 |
| Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial E Abraham, R Wunderink, H Silverman, TM Perl, S Nasraway, H Levy, ... Jama 273 (12), 934-941, 1995 | 1210 | 1995 |
| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 945 | 2020 |
| Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock E Abraham, A Anzueto, G Gutierrez, S Tessler, G San Pedro, ... The Lancet 351 (9107), 929-933, 1998 | 874 | 1998 |
| Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia RG Wunderink, J Rello, SK Cammarata, RV Croos-Dabrera, MH Kollef Chest 124 (5), 1789-1797, 2003 | 848 | 2003 |
| Angiotensin II for the treatment of vasodilatory shock A Khanna, SW English, XS Wang, K Ham, J Tumlin, H Szerlip, LW Busse, ... New England Journal of Medicine 377 (5), 419-430, 2017 | 705 | 2017 |
| International consensus guidelines for the optimal use of the polymyxins: endorsed by the American college of clinical pharmacy (ACCP), European society of clinical … BT Tsuji, JM Pogue, AP Zavascki, M Paul, GL Daikos, A Forrest, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (1 …, 2019 | 693 | 2019 |
| Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study RG Wunderink, MS Niederman, MH Kollef, AF Shorr, MJ Kunkel, A Baruch, ... Clinical Infectious Diseases 54 (5), 621-629, 2012 | 681 | 2012 |
| Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study E Rubinstein, SK Cammarata, TH Oliphant, RG Wunderink, ... Clinical Infectious Diseases 32 (3), 402-412, 2001 | 597 | 2001 |
| Ventilator-associated pneumonia due to Pseudomonas aeruginosa SC Brewer, RG Wunderink, CB Jones, KV Leeper Jr Chest 109 (4), 1019-1029, 1996 | 590 | 1996 |
| Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia RA Grant, L Morales-Nebreda, NS Markov, S Swaminathan, M Querrey, ... Nature 590 (7847), 635-641, 2021 | 586 | 2021 |
| Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin … MP Fink, DR Snydman, MS Niederman, KV Leeper Jr, RH Johnson, ... Antimicrobial agents and chemotherapy 38 (3), 547-557, 1994 | 572 | 1994 |
| Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia GW Waterer, GW Somes, RG Wunderink Archives of internal medicine 161 (15), 1837-1842, 2001 | 563 | 2001 |
| Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a … M Bassetti, R Echols, Y Matsunaga, M Ariyasu, Y Doi, R Ferrer, TP Lodise, ... The Lancet infectious diseases 21 (2), 226-240, 2021 | 508 | 2021 |
| High-dose, short-course levofloxacin for community-acquired Pneumonia: a new treatment paradig LM Dunbar, RG Wunderink, MP Habib, LG Smith, AM Tennenberg, ... Clinical infectious diseases 37 (6), 752-760, 2003 | 494 | 2003 |
| The radiologic diagnosis of autopsyproven ventilator-associated pneumonia RG Wunderink, LS Woldenberg, J Zeiss, CM Day, J Ciemins, DA Lacher Chest 101 (2), 458-463, 1992 | 452 | 1992 |
| Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia GU Meduri, GL Mauldin, RG Wunderink, KV Leeper Jr, CB Jones, E Tolley, ... Chest 106 (1), 221-235, 1994 | 451 | 1994 |
grant watererUniversity of Western Australia, Northwestern University Chicago, Royal Perth HospitalVerified email at uwa.edu.au
